Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Radiation Therapy for Unresectable Liver Metastases
NCT00892424Phase 2Completed
- Sponsor
- University Health Network
- Start
- Nov 2008
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in liver metastases, sponsored by University Health Network. Started Nov 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
liver metastases
Beyond the preview
Go deeper on NCT00892424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892424.